CID 146662764

Enbezotinib

Structural Information

Molecular Formula
C21H21FN6O3
SMILES
C[C@H]1CNC(=O)C2=C3N=C4C(=CN3N=C2)O[C@H]5CCC[C@H]5N4CC6=C(O1)N=CC(=C6)F
InChI
InChI=1S/C21H21FN6O3/c1-11-6-23-20(29)14-8-25-28-10-17-19(26-18(14)28)27(15-3-2-4-16(15)31-17)9-12-5-13(22)7-24-21(12)30-11/h5,7-8,10-11,15-16H,2-4,6,9H2,1H3,(H,23,29)/t11-,15+,16-/m0/s1
InChIKey
BYYQDEOVMILBQT-XZJROXQQSA-N
Compound name
(3S,7R,17S)-12-fluoro-17-methyl-2,16-dioxa-8,14,19,23,24,26-hexazahexacyclo[22.3.1.03,7.08,27.010,15.021,25]octacosa-1(28),10(15),11,13,21(25),22,26-heptaen-20-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

2
References

71
Patents

424.16592 Da
Monoisotopic Mass

1.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 425.17320 199.6
[M+Na]+ 447.15514 212.3
[M+NH4]+ 442.19974 204.6
[M+K]+ 463.12908 210.1
[M-H]- 423.15864 200.1
[M+Na-2H]- 445.14059 195.8
[M]+ 424.16537 201.2
[M]- 424.16647 201.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe